These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 32720120)
1. Ketogenic Diet for Malignant Gliomas: a Review. Thomas JG; Veznedaroglu E Curr Nutr Rep; 2020 Sep; 9(3):258-263. PubMed ID: 32720120 [TBL] [Abstract][Full Text] [Related]
2. Treatment of malignant gliomas with ketogenic or caloric restricted diets: A systematic review of preclinical and early clinical studies. Noorlag L; De Vos FY; Kok A; Broekman MLD; Seute T; Robe PA; Snijders TJ Clin Nutr; 2019 Oct; 38(5):1986-1994. PubMed ID: 30473444 [TBL] [Abstract][Full Text] [Related]
3. The ketogenic diet for the treatment of malignant glioma. Woolf EC; Scheck AC J Lipid Res; 2015 Jan; 56(1):5-10. PubMed ID: 24503133 [TBL] [Abstract][Full Text] [Related]
4. A ketogenic diet increases transport and oxidation of ketone bodies in RG2 and 9L gliomas without affecting tumor growth. De Feyter HM; Behar KL; Rao JU; Madden-Hennessey K; Ip KL; Hyder F; Drewes LR; Geschwind JF; de Graaf RA; Rothman DL Neuro Oncol; 2016 Aug; 18(8):1079-87. PubMed ID: 27142056 [TBL] [Abstract][Full Text] [Related]
5. Role of ketogenic metabolic therapy in malignant glioma: A systematic review. Winter SF; Loebel F; Dietrich J Crit Rev Oncol Hematol; 2017 Apr; 112():41-58. PubMed ID: 28325264 [TBL] [Abstract][Full Text] [Related]
6. Application of Bayesian evidence synthesis to modelling the effect of ketogenic therapy on survival of high grade glioma patients. Klement RJ; Bandyopadhyay PS; Champ CE; Walach H Theor Biol Med Model; 2018 Aug; 15(1):12. PubMed ID: 30122157 [TBL] [Abstract][Full Text] [Related]
7. Feasibility and Biological Activity of a Ketogenic/Intermittent-Fasting Diet in Patients With Glioma. Schreck KC; Hsu FC; Berrington A; Henry-Barron B; Vizthum D; Blair L; Kossoff EH; Easter L; Whitlow CT; Barker PB; Cervenka MC; Blakeley JO; Strowd RE Neurology; 2021 Aug; 97(9):e953-e963. PubMed ID: 34233941 [TBL] [Abstract][Full Text] [Related]
8. Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme. Champ CE; Palmer JD; Volek JS; Werner-Wasik M; Andrews DW; Evans JJ; Glass J; Kim L; Shi W J Neurooncol; 2014 Mar; 117(1):125-31. PubMed ID: 24442482 [TBL] [Abstract][Full Text] [Related]
9. The Modified Ketogenic Diet in Adults with Glioblastoma: An Evaluation of Feasibility and Deliverability within the National Health Service. Martin-McGill KJ; Marson AG; Tudur Smith C; Jenkinson MD Nutr Cancer; 2018; 70(4):643-649. PubMed ID: 29668317 [TBL] [Abstract][Full Text] [Related]
10. Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors: Artzi M; Liberman G; Vaisman N; Bokstein F; Vitinshtein F; Aizenstein O; Ben Bashat D J Neurooncol; 2017 Apr; 132(2):267-275. PubMed ID: 28074323 [TBL] [Abstract][Full Text] [Related]
11. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma. Poff A; Koutnik AP; Egan KM; Sahebjam S; D'Agostino D; Kumar NB Semin Cancer Biol; 2019 Jun; 56():135-148. PubMed ID: 29294371 [TBL] [Abstract][Full Text] [Related]
12. The role of ketogenic diets in the therapeutic management of adult and paediatric gliomas: a systematic review. Martin-McGill KJ; Srikandarajah N; Marson AG; Tudur Smith C; Jenkinson MD CNS Oncol; 2018 Apr; 7(2):CNS17. PubMed ID: 29658772 [TBL] [Abstract][Full Text] [Related]
13. Effect of ketogenic diets on leukocyte counts in patients with epilepsy. Schreck KC; Lwin M; Strowd RE; Henry-Barron BJ; Blakeley JO; Cervenka MC Nutr Neurosci; 2019 Jul; 22(7):522-527. PubMed ID: 29254457 [TBL] [Abstract][Full Text] [Related]
14. Ketogenic diets as an adjuvant therapy for glioblastoma (KEATING): a randomized, mixed methods, feasibility study. Martin-McGill KJ; Marson AG; Tudur Smith C; Young B; Mills SJ; Cherry MG; Jenkinson MD J Neurooncol; 2020 Mar; 147(1):213-227. PubMed ID: 32036576 [TBL] [Abstract][Full Text] [Related]
15. The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma. Abdelwahab MG; Fenton KE; Preul MC; Rho JM; Lynch A; Stafford P; Scheck AC PLoS One; 2012; 7(5):e36197. PubMed ID: 22563484 [TBL] [Abstract][Full Text] [Related]
16. The ketogenic diet for the treatment of glioma: insights from genetic profiling. Scheck AC; Abdelwahab MG; Fenton KE; Stafford P Epilepsy Res; 2012 Jul; 100(3):327-37. PubMed ID: 22019313 [TBL] [Abstract][Full Text] [Related]
17. Cerebral Ketones Detected by 3T MR Spectroscopy in Patients with High-Grade Glioma on an Atkins-Based Diet. Berrington A; Schreck KC; Barron BJ; Blair L; Lin DDM; Hartman AL; Kossoff E; Easter L; Whitlow CT; Jung Y; Hsu FC; Cervenka MC; Blakeley JO; Barker PB; Strowd RE AJNR Am J Neuroradiol; 2019 Nov; 40(11):1908-1915. PubMed ID: 31649157 [TBL] [Abstract][Full Text] [Related]
19. Feasibility of a modified Atkins diet in glioma patients during radiation and its effect on radiation sensitization. Woodhouse C; Ward T; Gaskill-Shipley M; Chaudhary R Curr Oncol; 2019 Aug; 26(4):e433-e438. PubMed ID: 31548811 [TBL] [Abstract][Full Text] [Related]
20. A ketogenic diet attenuates proliferation and stemness of glioma stem‑like cells by altering metabolism resulting in increased ROS production. Ji CC; Hu YY; Cheng G; Liang L; Gao B; Ren YP; Liu JT; Cao XL; Zheng MH; Li SZ; Wan F; Han H; Fei Z Int J Oncol; 2020 Feb; 56(2):606-617. PubMed ID: 31894296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]